Skip to main content
Premium Trial:

Request an Annual Quote

GenVault Raises $1.5M in VC Financing

This article has been updated from a previous version to clarify the fact that the current financing is part of the same round that the company raised in April.
 
NEW YORK (GenomeWeb News) — GenVault said today it has received $1.5 million in venture capital financing to help it develop and market its DNA-preservation technology.
 
GenVault’s platform is used to extract, preserve, recover, and distribute DNA at room temperature. The company also said it expects future storage systems to accommodate proteins and RNA.
 
The financing is part of an $18 million round GenVault raised in April from Domain Associates and QuestMark Partners, bringing the total funding raised in the round to $19.5 million.
 
The additional financing is from Cross Creek Capital, a private equity affiliate of Wasatch Advisors.
 
Karey Barker, Cross Creek’s managing director, said GenVault “presented investors with an unusual and timely opportunity to participate at the nexus of several new, diverse industries that rely on careful management and archiving of gene-related materials.”

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.